Paper

Abstract 6843: A joint model for integrating serial methylation-based tumor fraction and ESR1 assessment to forecast overall survival in patients with ER+/HER2- metastatic breast cancer.

Cancer Research · 2026 · Christopher R. Pretz, Matthew J. Ellis, Mitchell J. Elliott et al.